harpoontx.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi HARP
Harpoon Therapeutics develops cancer treatment methods via the TriTAC platform. The automation of antibody synthesis in laboratories accelerates drug release. Absolute operating profit reflects current cash flow dynamics, where represents the latest level value. The business valuation currently depends not on sales, but on the prospects of selling unique technologies through M&A transactions.
Harpoon Therapeutics, Inc. - rincian analitis lan metrik utama (HARP)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Harpoon Therapeutics|HARP - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Harpoon Therapeutics Inc|HARP - Utang perusahaan|Rasio utang marang nilai buku Harpoon Therapeutics|HARP - Utang jangka dawa perusahaan|Utang jangka cendhak Harpoon Therapeutics|Likuiditas kritis harpoontx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
HARP - Penghasilan resik|Bathi resik mangsa ngarep Harpoon Therapeutics|HARP - Pangali P/E|Pangali mangsa ngarep rega marang bathi harpoontx.com|HARP - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harpoon Therapeutics|HARP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Harpoon Therapeutics|HARP - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan harpoontx.com|HARP - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Harpoon Therapeutics
Analisis kabeh metrik perusahaan:Harpoon Therapeutics Corp - HARP
This metric reflects net cash flow from operating activities, excluding depreciation and accounting adjustments to assess real operational efficiency. By analyzing EBITDA, an investor can discern the business resilience of Harpoon Therapeutics (HARP) amid geopolitical barriers, which directly impact operating expense dynamics through biomaterial logistics disruptions and drug certification delays.
Pesaing Harpoon Therapeutics (HARP)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (Innate Pharma S.A) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|Cue Biopharma, Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology|sonnetbio.com (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LIMN (Liminatus Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA Lava Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NextCure (NXTC)|LPTX: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Intensity Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Sensei Biotherapeutics Inc (SNSE) - Bathi sadurunge bunga, pajak, lan amortisasi|Theriva Biologics, Inc. - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi GRTS (Gritstone bio, Inc.)|KA: Bathi operasional EBITDA|NexImmune Inc (NEXI) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Turnstone Biologics Corp|VCNX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi
